Valeo Financial Advisors LLC Trims Holdings in Humana Inc. (NYSE:HUM)

Valeo Financial Advisors LLC reduced its stake in shares of Humana Inc. (NYSE:HUM) by 13.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 985 shares of the insurance provider’s stock after selling 155 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Humana were worth $451,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in HUM. Gradient Investments LLC boosted its holdings in shares of Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the period. Sunbelt Securities Inc. purchased a new position in shares of Humana during the first quarter valued at $28,000. Householder Group Estate & Retirement Specialist LLC bought a new stake in shares of Humana in the third quarter valued at about $39,000. Nvwm LLC lifted its stake in Humana by 41.0% in the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after acquiring an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Humana during the 4th quarter worth about $55,000. 92.38% of the stock is currently owned by institutional investors.

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the stock in a transaction on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.29% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on HUM shares. Wells Fargo & Company reduced their price target on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Stephens reduced their price objective on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a research note on Friday, January 26th. Deutsche Bank Aktiengesellschaft cut Humana from a “buy” rating to a “hold” rating and dropped their target price for the company from $595.00 to $360.00 in a research report on Thursday, January 25th. Argus lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Finally, Truist Financial reaffirmed a “hold” rating and set a $550.00 price objective on shares of Humana in a research report on Friday, January 19th. Eleven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $465.42.

Humana Stock Down 1.2 %

Humana stock opened at $312.59 on Monday. The business’s 50-day moving average price is $347.21 and its 200 day moving average price is $428.90. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm has a market cap of $37.71 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 1.83 and a beta of 0.45. Humana Inc. has a 52 week low of $299.23 and a 52 week high of $541.21.

Humana (NYSE:HUM) last released its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). The company had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. Humana had a return on equity of 19.44% and a net margin of 2.34%. The company’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.62 EPS. As a group, sell-side analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.885 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. Humana’s dividend payout ratio (DPR) is currently 17.86%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.